Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001464583-26-000006

CHIEF ACCOUNTING OFFICER sold 6,625 shares at $46.69 ($309,321)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Megna Michael R · CHIEF ACCOUNTING OFFICER

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-04-09 Sale : show line 1 in the form 10b5-1 −6,625 $46.69 $309,321 27,418 D
Open-market sales · 6,625 sh · avg $46.69 · $309,321
Loading xslF345X06/form4-04132026_080442.xml…